MondayAug 26, 2019 1:57 pm

CannaPharmaRx Inc. (CPMD) Developing Cultivation Facilities Across Canada, Aiming to Build Profile in Burgeoning Industry

CannaPharmaRx is in the process of acquiring, funding and developing three significant cannabis cultivation sites in Ontario and British Columbia The company’s agreements with the facilities’ owners grant it access to cultivation sites that could return close to 300,000 pounds of product per year The global cannabis cultivation industry is expected to become a nearly $155 billion market by 2026 Real estate investment and early-stage pharmaceutical company CannaPharmaRx Inc. (OTC: CPMD) is advancing its plans to become a cannabis cultivator using proprietary formulation and drug delivery technology currently in development to expand in an industry that is evolving at an…

Continue Reading

MondayAug 26, 2019 1:31 pm

VPR Brands LP (VPRB) Reports 31% Jump in Sales, Uplists to OTCQB Venture Market

Citing larger distributor and private-label orders, VPRB reported revenues of $1.58 million for Q2 2019 The company also reported a 31 percent increase in sales VPRB attained an uplisting to the OCTQB Venture Market VPR Brands LP (OTCQB: VPRB), a multi-vertical, tiered company in the cannabis space, has increased its sales significantly through larger distributor and private-label orders, growing its quarterly figure to $1.58 million for the three-month period ended June 30 to record a 31 percent increase over the same period of 2018. VPRB also reported a 31 percent year-over-year sales increase for the six months ended June 30,…

Continue Reading

MondayAug 26, 2019 12:57 pm

Trxade Group Inc. (TRXD) Committed to Ensuring the Survival of Independent Pharmacies

Trxade Group is actively working to reverse a negative phenomenon known as ‘pharmacy deserts’ that is affecting many parts of the U.S. Trxade is providing a solution that empowers small, independent pharmacies by giving them access to competitive pricing and reliable supply options Due to the demand, Trxade Group is also working on new product offerings that will expand the predictive analytical capabilities of community-based and independent pharmacies As independent pharmacy businesses struggle to overcome various challenges, the U.S. is facing a growing problem with the so-called ‘pharmacy deserts’ phenomenon, which results in entire areas left without pharmacy services. One…

Continue Reading

MondayAug 26, 2019 12:16 pm

Earth Science Tech Inc. (ETST) Launches Home Detection Kit Aimed at Improving Women’s Health

Women’s health and access to medical amenities are huge concerns in both developed and developing nations ETST’s wholly owned subsidiary, Earth Science Pharm Inc., is dedicated to research, with a goal of eradicating STIs The company has launched Hygee, its home detection kits for screening STIs Earth Science Tech Inc. (OTCQB: ETST) is a Florida-based biotech company engaged in the production of premium-quality industrial hemp and cannabis/cannabidiol (CBD) products. ETST offers 100 percent organic and pure CBD oil, which is made using the supercritical CO2 liquid-extraction process. An innovative product aimed at improving women’s ability to self-screen for STIs was…

Continue Reading

MondayAug 26, 2019 11:55 am

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Acquires 824-Acre Potrero Ranch Hemp Cultivation Property

Innovative, full-scope, science-driven, premium hemp cultivation and branding enterprise Green Hygienics Holdings (OTCQB: GRYN) today announced completion of its previously disclosed acquisition of the 824-acre Potrero Ranch Property near San Diego, California. According to the update, the company will utilize the land and buildings for industrial hemp for CBD cultivation. “We have been working at the property under a lease agreement for the last two months purchasing equipment and preparing to begin cultivation immediately,” GRYN CEO Ron Loudoun stated in the news release. “The combination of the greenhouse space and acreage will create the capability to produce significant revenues for…

Continue Reading

MondayAug 26, 2019 11:47 am

Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Inks Agreement Increasing Cannabis Holdings in Arizona’s Greening Desert

Cannabis investment building company Nabis Holdings is establishing a profile of synergistic and vertical properties across the United States The company recently announced an agreement to gain 100 percent of the membership units in a Phoenix-based medical marijuana asset, including a dispensary in a community that serves more than 132,000 unique patients The acquisition adds to Nabis’ already growing profile in the state, including a broad dispensary network, cultivation facility and greenhouse north of Phoenix Nabis expects its revenues to see a sharp increase during the next two years with its acquisition strategy Vertically integrated cannabis specialty investment company Nabis…

Continue Reading

MondayAug 26, 2019 11:24 am

QualityStocksNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries Leases State- of-the-Art, Florida Based Hemp Processing and Manufacturing Facility

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, through its wholly owned subsidiary, Khrysos Industries, Inc., today announced that it has leased 82,000 square feet in Orlando, Florida to house its facility for post processing hemp derived products and finished goods manufacturing.  The state-of-the-art facility features a 46,200 square foot production area and is the former home of Nephron Pharmaceuticals GMP Certified sterile manufacturing operations. "We believe this facility provides us the opportunity to accelerate our post processing and manufacturing capabilities by approximately two years in terms of production output.  The amenities and…

Continue Reading

MondayAug 26, 2019 10:41 am

QualityStocksNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Headset Launches Cannabis Market Intelligence Tool in Canada

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, Headset, Inc., has launched its competitive cannabis market intelligence tool in Canada. Headset Insights is already trusted by hundreds of operators in numerous U.S. markets and provides users with real-time market data to help uncover strategic opportunities, monitor consumer trends and behaviors, and keep tabs on competitors. "This announcement from Headset is a testament to the company's rapid growth since being backed by RIV and joining our ecosystem in January 2019," Canopy Rivers President and CEO Narbe Alexandrian said in the news release. "We believe that Headset…

Continue Reading

MondayAug 26, 2019 9:59 am

QualityStocksNewsBreaks – SinglePoint, Inc.’s (SING) Direct Solar Enters Partnership with Inc 500 “A Fastest Growing Company” – My Home Group Real Estate, LLC.

Technology and investment company SinglePoint (OTCQB: SING) through its subsidiary, Direct Solar, this morning announced entry into a partnership with My Home Group Real Estate, LLC., named “A fastest growing company” by Inc 500 five years in a row, and Arizona’s number one and the nation’s second fastest growing residential real estate brokerage. Under the new partnership, My Home Group agents will be able to provide homeowners searching for cleaner alternative fuel systems or alternatives to reduce grid reliance or the burden of increasingly higher utility bills with eco-conscious energy options. “When a My Home Group real estate professional recommends…

Continue Reading

FridayAug 23, 2019 2:56 pm

QualityStocksNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Advances Clinical Development of INB03

INmune Bio (NASDAQ: INMB) co-founder and CEO Dr. RJ Tesi recently reported positive preliminary data from the company’s INB03 Phase I clinical trial in cancer patients during a presentation at Cambridge Healthtech Institute’s 7th Annual Immuno-Oncology Summit in Boston (http://ibn.fm/m1Iy3). An article discussing the company reads, “‘The goal of the Phase I study is to determine, in order of priority, the safety of INB03 in cancer patients, the dose of INB03 to take into the Phase II trials in cancer, and evidence of a biologic effect of INB03,’ stated Tesi, who is also INmune Bio’s chief medical officer. ‘All of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered